Vaccination coverage among adults, excluding influenza vaccination - United States, 2013
- PMID: 25654611
- PMCID: PMC4584858
Vaccination coverage among adults, excluding influenza vaccination - United States, 2013
Abstract
Vaccinations are recommended throughout life to prevent vaccine-preventable diseases and their sequelae. Adult vaccination coverage, however, remains low for most routinely recommended vaccines and below Healthy People 2020 targets. In October 2014, the Advisory Committee on Immunization Practices (ACIP) approved the adult immunization schedule for 2015. With the exception of influenza vaccination, which is recommended for all adults each year, other adult vaccinations are recommended for specific populations based on a person's age, health conditions, behavioral risk factors (e.g., injection drug use), occupation, travel, and other indications. To assess vaccination coverage among adults aged ≥19 years for selected vaccines, CDC analyzed data from the 2013 National Health Interview Survey (NHIS). This report highlights results of that analysis for pneumococcal, tetanus toxoid-containing (tetanus and diphtheria vaccine [Td] or tetanus and diphtheria with acellular pertussis vaccine [Tdap]), hepatitis A, hepatitis B, herpes zoster (shingles), and human papillomavirus (HPV) vaccines by selected characteristics (age, race/ethnicity,† and vaccination indication). Influenza vaccination coverage estimates for the 2013-14 influenza season have been published separately. Compared with 2012, only modest increases occurred in Tdap vaccination among adults aged ≥19 years (a 2.9 percentage point increase to 17.2%), herpes zoster vaccination among adults aged ≥60 years (a 4.1 percentage point increase to 24.2%), and HPV vaccination among males aged 19-26 years (a 3.6 percentage point increase to 5.9%); coverage among adults in the United States for the other vaccines did not improve. Racial/ethnic disparities in coverage persisted for all six vaccines and widened for Tdap and herpes zoster vaccination. Increases in vaccination coverage are needed to reduce the occurrence of vaccine-preventable diseases among adults. Awareness of the need for vaccines for adults is low among the general population, and adult patients largely rely on health care provider recommendations for vaccination. The Community Preventive Services Task Force and the National Vaccine Advisory Committee have recommended that health care providers incorporate vaccination needs assessment, recommendation, and offer of vaccination into every clinical encounter with adult patients to improve vaccination rates and to narrow the widening racial/ethnic disparities in vaccination coverage.
Similar articles
-
Noninfluenza vaccination coverage among adults - United States, 2012.MMWR Morb Mortal Wkly Rep. 2014 Feb 7;63(5):95-102. MMWR Morb Mortal Wkly Rep. 2014. PMID: 24500288 Free PMC article.
-
Surveillance of Vaccination Coverage Among Adult Populations -United States, 2018.MMWR Surveill Summ. 2021 May 14;70(3):1-26. doi: 10.15585/mmwr.ss7003a1. MMWR Surveill Summ. 2021. PMID: 33983910 Free PMC article.
-
Surveillance of Vaccination Coverage among Adult Populations - United States, 2015.MMWR Surveill Summ. 2017 May 5;66(11):1-28. doi: 10.15585/mmwr.ss6611a1. MMWR Surveill Summ. 2017. PMID: 28472027 Free PMC article.
-
Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP).MMWR Recomm Rep. 2008 May 30;57(RR-4):1-51. MMWR Recomm Rep. 2008. PMID: 18509304 Review.
-
Vaccines for older adults.Consult Pharm. 2009 May;24(5):380-91. doi: 10.4140/tcp.n.2009.380. Consult Pharm. 2009. PMID: 19555147 Review.
Cited by
-
Peripheral Artery Disease and Subsequent Risk of Infectious Disease in Older Individuals: The ARIC Study.Mayo Clin Proc. 2022 Nov;97(11):2065-2075. doi: 10.1016/j.mayocp.2022.03.038. Epub 2022 Oct 7. Mayo Clin Proc. 2022. PMID: 36210200 Free PMC article.
-
Determining the Optimal Vaccination Schedule for Herpes Zoster: a Cost-Effectiveness Analysis.J Gen Intern Med. 2017 Feb;32(2):159-167. doi: 10.1007/s11606-016-3844-6. Epub 2016 Oct 14. J Gen Intern Med. 2017. PMID: 27743284 Free PMC article.
-
Suboptimal uptake of human papillomavirus (HPV) vaccine in survivors of childhood and adolescent and young adult (AYA) cancer.J Cancer Surviv. 2019 Oct;13(5):730-738. doi: 10.1007/s11764-019-00791-9. Epub 2019 Jul 24. J Cancer Surviv. 2019. PMID: 31342304 Free PMC article.
-
Identification of potential missed opportunities for human papillomavirus (HPV) vaccination in women referred to an academic colposcopy clinic for evaluation of abnormal cervical cytology.Hum Vaccin Immunother. 2016 Jun 2;12(6):1639-45. doi: 10.1080/21645515.2015.1110658. Epub 2016 Feb 2. Hum Vaccin Immunother. 2016. PMID: 26839185 Free PMC article.
-
Assessment of Perceived Barriers to Herpes Zoster Vaccination among Geriatric Primary Care Providers.Pharmacy (Basel). 2016 Oct 18;4(4):30. doi: 10.3390/pharmacy4040030. Pharmacy (Basel). 2016. PMID: 28970403 Free PMC article.
References
-
- Kim DK, Bridges CB, Harriman KH. Advisory Committee on Immunization Practices recommended immunization schedule for adults aged 19 years or older: United States, 2015. Ann Intern Med. 2015;162:214–23. - PubMed
-
- CDC. Flu vaccination coverage, United States, 2013–14 influenza season. Atlanta, GA: US Department of Health and Human Services, CDC; 2013. Available at http://www.cdc.gov/flu/fluvaxview/coverage-1314estimates.htm.
-
- Community Preventive Services Task Force. The guide to community preventive services Increasing appropriate vaccination: universally recommended vaccinations. Atlanta, GA: US Department of Health and Human Services, CDC; 2011. Available at http://www.thecommunityguide.org/vaccines/index.html.